Leptin Decreases FoxO3a Activity and Increases PGC-1α Protein in Gastrocnemius Muscle. by Neira Sáinz (260167)

RNF5 loss decreases PEL xenograft tumor growth and cell cycle gene expression. by Xiaojuan Li (351842)

FABP5 down regulation increases inflammation but decreases innate immunity in primary NHBE cells. by Fabienne Gally (260470)

“…<p><b>A.</b> CS exposure increases <i>P. aeruginosa</i> colony forming units (CFU) on FABP5 knocked down primary NHBE cells. …”

Metformin decreases ATP levels in medium containing low glucose (2.5 mM). by Yongxian Zhuang (634693)

Overexpression of FTH1P3 decreased the miR-224-5p expression. by Xiaoli Zheng (232806)

“…<p>(A) Elevated expression of FTH1P3 decreased the miR-224-5p expression in the MUM-2B cell. …”

Toxoplasma infection leads to a decrease in the concentration of EVs. by Emily Z. Tabaie (16630841)

RGDfV increases ASM mRNA, ASM activity and ceramide levels and decreases sphingomyelins. by Xiuhai Ren (312555)

I348T increases H77 entry dependency on SR-BI, while T385P decreases H77 entry dependency on SR-BI. by Christina Holmboe Olesen (11154333)

TviA is involved in a rapid decrease in flagella expression in serum. by Sebastian E. Winter (133801)

Cardamonin decreased the protein expression of lipogenic proteins. by Peiguang Niu (17044532)

Uniportal VATS Right Lower Lobectomy and Lymphadenectomy: Step-by-Step by Hussein Elkhayat (4426768)

“…The authors present a case of right lower lobe lobectomy for adenocarcinoma with a step-by-step approach, in which they demonstrate how to use advanced instrumentation in uniportal VATS in order to decrease the number of instruments used and to get the best exposure inside the chest.…”

BST2 overexpression decreased RSV multiplication. by Katherine Marougka (13015146)

Depletion of Cholesterol Is Associated with a Decrease of Nonmethylated Sterols by Vitali Matyash (56893)

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

Reduced callose synthesis in <i>pat</i> is associated with the decreased <i>CalS5</i> expression. by Shuang-Xi Xiong (8844044)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”